DATS is designed to connect young investigators in the field of antisense therapeutics to strengthening the field in the Netherlands ๐ณ๐ฑ and beyond ๐ณ๏ธโ๐
Our national keynote is Dr. Marjon Pasmooij from the Science Department af the Dutch Medicines Evaluation Board and the UMCU where she holds an Associate Professorship on Drug Regulatory Science. A nice example on how to combine academia with drug regulatory affairs!
I am walking the 4daagse once again! I was too busy to start a fundraising campaign, but I will be walking once again for @Oogfonds. Today I walked 23,4 km from Nijmegen to Arnhem as part of my training. If you want to support me this is the link: https://t.co/osNMPpDDry
To all PhD candidates working on individualized ASOs in NL. The #DCRT is giving out 3 travel grants of 1,500 EUR to attend this year's OTS. Deadline is 1st July. For more information, follow the link: https://t.co/vkWXDPKwGm
@collinrwj @roon_mom @oligogirl@Jandritu
To all PhD candidates working on individualized ASOs in NL. The #DCRT is giving out 3 travel grants of 1,500 EUR to attend this year's OTS. Deadline is 1st July. For more information, follow the link: https://t.co/vkWXDPKwGm
@collinrwj @roon_mom @oligogirl@Jandritu
#apaperaday final @Dutch_Antisense#DATS2024 pick from Suarez-Herrera et al including today's keynote @collinrwj from @Cells_MDPI on developing an antisense oligonucleotide (ASO) for a very rare ABCA4 mutation for a patient with Stargardt disease DOI: 10.3390/cells13070601
#DATS2024 seems to be inspiring for @oligogirl as she is creating a zoo. Funny enough, in Rotterdam there is the Blijdorp Zoo, perhaps at the end of the meeting we need to release them there?
We had a great keynote lecture given by Shalini Andersson from @AstraZeneca. We learnt about siRNA, ASO, conjugates, and endosomal escape amongst many different interedting topics
The last young researcher is Manon Bouckaert from Ghent univeristy (@CoppietersF@ElfrideDe) talking about targeting variants in the 5โUTRs, which are frequently overlooked #DATS2024
The first #DATS2024 keynote lecture is given by Shalini Andersson from @AstraZeneca.
"Generating specific medicine for specific patient populations is important"